MAPK8 and Cognitive impairment: Activated JNK and GSK-3β downregulation may contribute to the downregulation of antioxidant proteins, thereby exacerbating synaptic dysfunction, neuroinflammatory responses, and cognitive deficits associated with neurodegeneration.